DrRaffaellaGadaleta

Faculty of Medicine, Department of Metabolism, Digestion and Reproduction

Honorary Research Associate

Contact

+44 (0)20 7594 2805r.gadaleta

Location

140ICTEM buildingHammersmith Campus

Summary

Publications

Journals

Magnani L, Frige G, Gadaleta RM, et al.Magnani L, Frige G, Gadaleta RM, Corleone G, Fabris S, Kempe MH, Vershure PJ, Barozzi I, Vircillo V, Hong S, Perone Y, Saini M, Trumpp A, Viale G, Neri A, Simak A, Colleoni MA, Pruneri G, Minucci S close, 2017, Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer, Nature Genetics, Vol:49, ISSN:1546-1718, Pages:444-450

Pellicciari R, Passeri D, De Franco F, et al.Pellicciari R, Passeri D, De Franco F, Mostarda S, Filipponi P, Colliva C, Gadaleta RM, Franco P, Carotti A, Macchiarulo A, Roda A, Moschetta A, Gioiello A close, 2016, Discovery of 3 alpha,7 alpha,11 beta-Trihydroxy-6 alpha-ethyl-5 beta-cholan-24-oic Acid (TC-100), a Novel Bile Acid as Potent and Highly Selective FXR Agonist for Enterohepatic Disorders, Journal of Medicinal Chemistry, Vol:59, ISSN:0022-2623, Pages:9201-9214

Gadaleta RM, Cariello M, Sabba C, et al.Gadaleta RM, Cariello M, Sabba C, Moschetta A close, 2015, Tissue-specific actions of FXR in metabolism and cancer, Biochimica Et Biophysica Acta-molecular and Cell Biology of Lipids, Vol:1851, ISSN:1388-1981, Pages:30-39

Gadaleta RM, Magnani L, 2014, Nuclear receptors and chromatin: an inducible couple, Journal of Molecular Endocrinology, Vol:52, ISSN:0952-5041, Pages:R137-R149

van Schaik FDM, Gadaleta RM, Schaap FG, et al.van Schaik FDM, Gadaleta RM, Schaap FG, van Mil SWC, Siersema PD, Oldenburg B, van Erpecum KJ close, 2012, Pharmacological Activation of the Bile Acid Nuclear Farnesoid X Receptor Is Feasible in Patients with Quiescent Crohn's Colitis, Plos One, Vol:7, ISSN:1932-6203

More Publications